2,2',2''-terpyridine has been researched along with neocuproine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doh-Ura, K; Fukuuchi, T; Ohta, S; Yoshihara, S | 1 |
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
Engel-Andreasen, J; Frimurer, TM; Gloriam, DE; Malmgaard-Clausen, M; Nielsen, MC; Rosenkilde, MM; Rummel, PC; Steen, A; Thiele, S; Ulven, T | 1 |
Bashkin, JK; Daniher, AT; Putnam, WC; Trawick, BN | 1 |
5 other study(ies) available for 2,2',2''-terpyridine and neocuproine
Article | Year |
---|---|
Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.
Topics: Cell Line; Chelating Agents; Copper; Molecular Structure; Prions; Spectrum Analysis; Structure-Activity Relationship; Superoxide Dismutase | 2006 |
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |
Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
Topics: Allosteric Regulation; Animals; Binding Sites; Chelating Agents; Chlorocebus aethiops; Copper; COS Cells; Glutamic Acid; Humans; Ligands; Models, Molecular; Organometallic Compounds; Protein Structure, Tertiary; Pyridines; Receptors, CCR; Substrate Specificity; Zinc | 2012 |
Efficient new ribozyme mimics: direct mapping of molecular design principles from small molecules to macromolecular, biomimetic catalysts.
Topics: Base Sequence; Catalysis; Cations, Divalent; Copper; Dimerization; Drug Design; Kinetics; Ligands; Molecular Mimicry; Molecular Structure; Phenanthrolines; Pyridines; RNA; RNA Probes; RNA, Catalytic; Structure-Activity Relationship; Substrate Specificity | 2001 |